Triple
T26020777
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | FDA Risk Evaluation and Mitigation Strategies authority |
E647147
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | drug safety authority |
C19042
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: drug safety authority Context triple: [FDA Risk Evaluation and Mitigation Strategies authority, instanceOf, drug safety authority]
-
A.
pharmacovigilance body
chosen
A pharmacovigilance body is an organization responsible for monitoring, assessing, and preventing adverse effects or other drug-related problems to ensure the ongoing safety and effective use of medicines.
-
B.
pharmacy regulator
A pharmacy regulator is an authority or organization responsible for overseeing, licensing, and enforcing standards for pharmacies and pharmacists to ensure the safe, ethical, and effective use of medications.
-
C.
center of the U.S. Food and Drug Administration
The center of the U.S. Food and Drug Administration is the primary organizational unit within the FDA responsible for regulating and overseeing a specific category of products, such as drugs, biologics, or medical devices, to ensure their safety and effectiveness.
-
D.
U.S. Food and Drug Administration center
A U.S. Food and Drug Administration center is a specialized organizational unit within the FDA responsible for regulating and overseeing specific categories of products, such as drugs, biologics, medical devices, or food, to ensure their safety, effectiveness, and proper labeling.
-
E.
organ of the European Medicines Agency
An organ of the European Medicines Agency is a formal decision-making or advisory body within the EMA’s governance structure, such as its Management Board, Executive Director, or scientific committees, responsible for specific regulatory, administrative, or scientific functions.
- F. None of above.
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e77e8aa65881909ca58918f29ab2a0 |
completed | April 21, 2026, 1:41 p.m. |
Created at: April 22, 2026, 9:03 a.m.